Status:
COMPLETED
Fertility Preservation in Cases of Klinefelter Syndrome.
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Klinefelter Syndrome
Eligibility:
MALE
15-55 years
Phase:
NA
Brief Summary
Klinefelter Syndrome (KS) is the most common sex chromosomal abnormalities (1/600 newborn males), and is characterized by a hypergonadism hypogonadism. Until few years ago, mostly non-mosaic KS was co...
Eligibility Criteria
Inclusion
- Klinefelter Syndrome with 47,XXY non-mosaic
- Androgenotherapy stopped since more than 6 months
Exclusion
- Antecedent of Radiotherapy or chemotherapy
- Psychological trouble
- Treatment interfering with spermatogenesis
- Androgenotherapy non stopped
Key Trial Info
Start Date :
September 20 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2018
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT01918280
Start Date
September 20 2010
End Date
September 17 2018
Last Update
December 19 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Biologie de la Reproduction - CECOS - Groupe Hospitalier Pellegrin
Bordeaux, France, 33076
2
Service d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie Est, Hospices Civils de Lyon
Bron, France, 69677
3
Service de Biologie de la Reproduction - Hôpital de la Conception
Marseille, France, 13385
4
Groupe de Médecine de la Reproduction - CECOS Midi-Pyrénées - Hôpital Paule de Viguier)
Toulouse, France, 31059